Japanese
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Inhalation Toxicology 2002-Sep

Aniline-induced methemoglobinemia in dogs: pitfalls of route-to-route extrapolations.

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
リンクがクリップボードに保存されます
Jürgen Pauluhn

キーワード

概要

Two groups of four beagle dogs each were exposed head-only to aniline vapor in concentrations of 155 or 174 mg/m(3) air for a duration of 4 h in order to attain a targeted total exposure dose of approximately 15 mg aniline/kg body weight. One group of dogs received this calculated dose also by gavage. Dose estimates were made either by the determination of aniline-serum albumin adducts or by repeated measurements of the respiratory minute volume during the inhalation exposure period. The magnitude of methemoglobin (MetHb) produced following each route served as the basis for comparison. MetHb levels were maximal at the end of the inhalation exposure period, attaining approximately 5%, whereas administration by gavage produced a maximum MetHb response of 26%. Measurements of respiratory minute volumes in individual dogs appear to suggest that variability in MetHb formation depends solely on the rate of uptake (ventilation). The concentration of aniline-serum albumin adducts and the extent of MetHb formation showed a nonproportional relationship. In summary, this study demonstrates that for aniline, an agent known to be bioactivated by a hepatic first-pass metabolism, the conversion of findings obtained from oral dosing to inhalation exposure concentrations is subject to overestimating dramatically the magnitude of MetHb formation likely to occur following inhalation exposure. As to whether the fivefold lower potency by inhalation is solely related to the hepatic first-pass bioactivation, to the rate of delivery, or to a less than 100% retention of the inhaled vapor within the respiratory tract remains to be elucidated. This study demonstrates some of the pitfalls that can occur in context with route-to-route extrapolations and reinforces many of the concerns related to such extrapolations.

Facebookページに参加する

科学に裏打ちされた最も完全な薬草データベース

  • 55の言語で動作します
  • 科学に裏打ちされたハーブ療法
  • 画像によるハーブの認識
  • インタラクティブGPSマップ-場所にハーブをタグ付け(近日公開)
  • 検索に関連する科学出版物を読む
  • それらの効果によって薬草を検索する
  • あなたの興味を整理し、ニュース研究、臨床試験、特許について最新情報を入手してください

症状や病気を入力し、役立つ可能性のあるハーブについて読み、ハーブを入力して、それが使用されている病気や症状を確認します。
*すべての情報は公開された科学的研究に基づいています

Google Play badgeApp Store badge